US Market for Hematology Devices - 2016 (Forecasted to 2022)
|出版商||iData Research Inc.||商品編碼||344798|
|出版日期||內容資訊||英文 48 Pages
|血液分析設備的美國市場：2016年 (至2022年的預測) US Market for Hematology Devices - 2016 (Forecasted to 2022)|
|出版日期: 2015年10月01日||內容資訊: 英文 48 Pages||
美國的血液分析用設備市場中，大型設備的市場成熟化，不過，小型設備方面，受到(促進早期診斷) 醫療制度改革的恩惠，預期打開了開業醫生 (POL) 之需求為中心的新市場機會。另一方面，醫療費償付制度的修訂可能帶給市場負面影響。
本報告提供美國的血液分析產品的市場相關分析、市場整體結構和近幾年的市場形勢、資本交易趨勢調查、各領域 (血液分析設備、試劑) 的市場結構和市場規模趨勢 (治療數量等) 詳細趨勢估計、考察。
Hematology analyzers discussed in this market include low-volume and high-volume systems. Low- volume systems, commonly found in decentralized labs, smaller commercial labs, physician office labs (POLs) and other near patient clinics, are three-part differentials and compact in size with cell counting as their primary function. High-volume analyzers, found in core labs and large reference labs, include additional parameters and typically have microscopy or image-processing capabilities. The high-volume analyzer market is at a mature stage due to extended life spans and improved durability of the systems; growth opportunities, however, exist in the low-volume segment, particularly in the POL market, due to the emergence of the outcomes-based health care delivery, which is resulting in higher volumes of testing being done during the patient visits owing to the advantages of early detection and timely treatment.
On the other hand, the growth of hematology testing in smaller private labs, POLs and other near patient clinics will be challenged by the implementation of the market-based fee adjustments to the CMS Clinical Laboratory Fee Schedule (CLFS), beginning January 2017. Consequently, one of the most routine high-volume lab tests, the complete blood count (CBC), is expected to witness lower reimbursements due to the economies of scale and low costs in large automated private labs and core labs of hospitals, which account for more than 65% of the hematology testing. Consequently, rates paid by CMS and private insurance players may not account for the higher costs to perform the tests in POLs and smaller clinics.
Beckman Coulter was the hematology market leader in 2015 with almost half of the entire market. Their high end analyzers and low end analyzers meet the needs of nearly any hematology testing environment. Close competitors in this space include Sysmex America, Abbott Diagnostics, Siemens Healthcare Diagnostics, Horiba, and others.
This Report includes extensive detail on:
This Report Also Includes:
To Get The Most of this report:
Combine it with our other US market reports on, Hemostasis, Immunochemistry, Molecular Diagnostics, Blood Donor Screening, or Point of Care Diagnostic Devices.